SORLIS
Pressure Ulcers Prevention and Monitoring Platform
Company Overview
Snapshot
Founded in July 2023 by Waseem Geraisy and Micha Nisani, SORLIS operates with 1–10 employees. The company has raised $500,000 across one funding round from one investor. In February 2024, SORLIS secured seed funding from Takwin.
Business overview
SORLIS is a Health Tech & Life Sciences company focused on developing solutions for the early detection and prevention of pressure ulcers. The company's core technology aims to identify pressure injuries at their onset, thereby alleviating patient suffering, streamlining medical staff workflows, and reducing healthcare costs. SORLIS serves the healthcare industry, specifically targeting providers with its B2B business model, and operates within the Medical Devices and Diagnostics Devices sectors.
Log in to access full profile ›Company Intelligence Q&A
- When was SORLIS founded?
- SORLIS was founded in July 2023.
- Who are the founders of SORLIS?
- The co-founders of SORLIS are Waseem Geraisy, who serves as CEO, and Micha Nisani, who is the CTO.
- What is SORLIS's primary focus?
- SORLIS is dedicated to transforming healthcare through the early detection and prevention of pressure ulcers.
- What is the total capital raised by SORLIS?
- SORLIS has raised a total of $500,000 in funding.
- Which investor participated in SORLIS's seed funding round?
- In February 2024, SORLIS secured seed funding from Takwin.